AstraZeneca wins bipolar disorder drug patent case for Seroquel XR

Read more:

AstraZeneca PLC says it has won a judgment in a U.S. court protecting its patent on the extended release version of Seroquel, its blockbuster drug for treating bipolar disorder.

AstraZeneca said Friday that U.S. District Court in New Jersey upheld the formulation patent for Seroquel XR, which expires in 2017.

The company said the court also ruled that Anchen Pharmaceuticals, Inc., Osmotica Pharmaceutical Corp., Torrent Pharmaceuticals Ltd., Torrent Pharma Inc., Mylan Pharmaceuticals Inc. and Mylan Inc. have infringed the patent.

AstraZeneca has also been fighting legal battles to protect its patent on quetiapine, the active ingredient in Seroquel, which expires in December. Seroquel is the company’s second-largest-selling brand, accounting for 17 per cent of sales last year.

1 Comment

Leave a Reply

Breaking the Link of Violence and Mental Illness

  That’s the title of the tweet from the New York Times that caught my eye.   From an article published yesterday, Warning Signs of Violent Acts Often Unclear:   No one but a deeply disturbed individual marches into an elementary school or a movie theater and guns down random, innocent …

Zero to Pissed in 2.4 Seconds – ‘Appropriate’ Reaction or Bipolar BS

  Shit happens.   And, as a result of my Bipolar Disorder, every time shit goes down and I have to suddenly engage, I am always petrified when it’s all over.  I took action to correct a bad situation, but was my judgement sound?  Did I do the right thing? …

Study Questions Effectiveness of Therapy for Suicidal Teenagers

From today’s New York Times:∣=tw-nytimes&_r=0 [Updated Jan 11 – because the WP app for my phone I posted this from is less than stellar.] Teenage years are very difficult.  Trying to help a suicidal teen is ten times more difficult.  What is as disturbing as it is unfortunate is …

error: Content is protected !!